Ramachandran, R.; Cannon, M.; Peshin, S.; Kundranda, M.; Scott, A.J.
Unveiling ctDNA Response: Immune Checkpoint Blockade Therapy in a Patient with POLE Mutation-Associated Early-Onset Colon Cancer. Curr. Oncol. 2025, 32, 370.
https://doi.org/10.3390/curroncol32070370
AMA Style
Ramachandran R, Cannon M, Peshin S, Kundranda M, Scott AJ.
Unveiling ctDNA Response: Immune Checkpoint Blockade Therapy in a Patient with POLE Mutation-Associated Early-Onset Colon Cancer. Current Oncology. 2025; 32(7):370.
https://doi.org/10.3390/curroncol32070370
Chicago/Turabian Style
Ramachandran, Ramya, Marisa Cannon, Supriya Peshin, Madappa Kundranda, and Aaron J. Scott.
2025. "Unveiling ctDNA Response: Immune Checkpoint Blockade Therapy in a Patient with POLE Mutation-Associated Early-Onset Colon Cancer" Current Oncology 32, no. 7: 370.
https://doi.org/10.3390/curroncol32070370
APA Style
Ramachandran, R., Cannon, M., Peshin, S., Kundranda, M., & Scott, A. J.
(2025). Unveiling ctDNA Response: Immune Checkpoint Blockade Therapy in a Patient with POLE Mutation-Associated Early-Onset Colon Cancer. Current Oncology, 32(7), 370.
https://doi.org/10.3390/curroncol32070370